Mutations in the iduronate-2-sulfatase gene in five Norwegians with Hunter syndrome.

Article Details

Citation

Olsen TC, Eiken HG, Knappskog PM, Kase BF, Mansson JE, Boman H, Apold J

Mutations in the iduronate-2-sulfatase gene in five Norwegians with Hunter syndrome.

Hum Genet. 1996 Feb;97(2):198-203.

PubMed ID
8566953 [ View in PubMed
]
Abstract

We have identified the mutations in the iduronate-2-sulfatase (IDS) gene of five unrelated Norwegians with Hunter syndrome by reverse transcription-polymerase chain reaction (RT-PCR) analysis of IDS mRNA followed by single strand conformation polymorphism (SSCP) analysis and cDNA sequencing. One patient had a 5-bp deletion, located at the intron 5/exon 6 junction, that created a new alternative splice site. This expanded the deletion to 9 bp in mRNA, an in-frame deletion of the first 3 codons of exon 6 of the IDS gene. In two patients point mutations were identified, the S333L mutation, which has been reported previously, and A346D (a C-->A transversion at nucleotide 1161/exon 8), which is novel. Two patients had large 3' mRNA rearrangements. The A346D mutation was associated with the mild phenotype, all others with the severe form.

DrugBank Data that Cites this Article

Polypeptides
NameUniProt ID
Iduronate 2-sulfataseP22304Details